Neuroprotective potential of dendritic cells and sirtuins in multiple sclerosis

F Piacente, M Bottero, A Benzi, T Vigo… - International journal of …, 2022 - mdpi.com
Myeloid cells, including parenchymal microglia, perivascular and meningeal macrophages,
and dendritic cells (DCs), are present in the central nervous system (CNS) and establish an …

Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis

C Liu, J Zhu, Y Mi, T Jin - Journal of Neuroinflammation, 2022 - Springer
Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs),
which play a pivotal role in inducing either inflammatory or tolerogenic response based on …

Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice

AG Vakrakou, ME Brinia, A Alexaki… - International …, 2023 - Elsevier
The expanded treatment landscape in relapsing-remitting multiple sclerosis (MS) has
resulted in highly effective treatment options and complexity in managing disease-or drug …